Tamoxifen, the well recognized antiestrogen, is known to bind with the receptor for the hormone, thus preventing its growth stimulating effect on breast cancer cells. A new study reveals that in addition, tamoxifen stimulates the expression of the tumor suppressor gene maspin. This observation may lead to the development of a new class of drugs targeting the maspin gene.
Go to Previous Page
Go to Next Page